Pulmatrix Inc (PULM)
2.020
+0.01
(+0.25%)
USD |
NASDAQ |
Apr 23, 16:00
2.07
+0.05
(+2.47%)
Pre-Market: 20:00
Pulmatrix Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.3353 |
| December 31, 2017 | 0.3177 |
| September 30, 2017 | 0.3049 |
| June 30, 2017 | 0.2881 |
| March 31, 2017 | 0.3259 |
| December 31, 2016 | 0.6624 |
| September 30, 2016 | 0.3666 |
| June 30, 2016 | 0.3365 |
| March 31, 2016 | 0.2397 |
| December 31, 2015 | 0.2061 |
| September 30, 2015 | 0.1873 |
| June 30, 2015 | 0.1706 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 33.96M |
| Total Liabilities (Quarterly) | 15.96M |
| Shareholders Equity (Quarterly) | 18.00M |
| Current Ratio | 5.332 |